OnDemand Visit is a platform for healthcare providers to manage their own virtual care offerings, as an alternative to outsourcing their telemedicine needs and services.
The direct-to-consumer telehealth platform connects patients with providers for a real-time medical visit, through any mobile or PC device.
A virtual connection takes place in minutes, eliminating the need for patients to travel to an appointment for simple acute conditions or chronic disease management.
Some key features of OnDemand Visit include ad hoc or scheduled visits, secure video or audio calls, geo location and tracking, e-prescribing, lab ordering, digital health wallet, and EHR integration.
AMD Global Telemedicine pioneered the Telemedicine Encounter Management Solutions (TEMS) to over 9,000 patient end-points in more than 98 countries.
The company provides personalized telemedicine solutions, pairing its TEMS technology with specialized medical devices and video communication technologies, in order to connect a patient with a remote clinical healthcare provider.
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch